Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitro. | Clin Exp Immunol;116(1): 48-56, 1999 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitro.

Pettit, S J; Ali, S; O'Flaherty, E; Griffiths, T R; Neal, D E; Kirby, J A.

Affiliation

Pettit SJ; Department of Surgery, Medical School, University of Newcastle Upon Tyne, UK.

Clin Exp Immunol ; 116(1): 48-56, 1999 Apr.

Article in En | MEDLINE | ID: mdl-10209504

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Membrane Glycoproteins / Lymphocyte Activation / CD4-Positive T-Lymphocytes / Antigens, CD / B7-1 Antigen Limits: Humans Language: En Journal: Clin Exp Immunol Year: 1999 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Membrane Glycoproteins / Lymphocyte Activation / CD4-Positive T-Lymphocytes / Antigens, CD / B7-1 Antigen Limits: Humans Language: En Journal: Clin Exp Immunol Year: 1999 Document type: Article Affiliation country: Country of publication: